Gülcan, Hayrettin O <br/><br/>
Marginally designed new profen analogues have the potential to inhibit cyclooxygenase enzymes.  [electronic resource] 

 -  Archiv der Pharmazie  Jan 2015 
 - 55-61 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1521-4184 
<br/><br/><label>Standard No.: </label>10.1002/ardp.201400366  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Arachidonate 5-Lipoxygenase--metabolism<br/>Cyclooxygenase 1--metabolism<br/>Cyclooxygenase 2--metabolism<br/>Cyclooxygenase 2 Inhibitors--chemical synthesis<br/>Cyclooxygenase Inhibitors--chemical synthesis<br/>Drug Design<br/>Flurbiprofen--chemical synthesis<br/>Ibuprofen--analogs & derivatives<br/>Lipoxygenase Inhibitors--chemical synthesis<br/>Molecular Structure<br/>Naproxen--chemical synthesis<br/>Propionates--chemical synthesis<br/>Structure-Activity Relationship